Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.SummaryDifference0.0%

- Check19 days agoChange DetectedVersion bump from v3.4.0 to v3.4.1. No visible changes to the study details page.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive study information appears to be modified.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now includes an administrative update showing the last known status with sponsor RemeGen Co., Ltd.; date 2023-12; verification status 'Verified'; and 'Unknown status'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedAdded Beijing Municipality as a study location under Locations. Removed the HHS Vulnerability Disclosure and the Beijing Municipality Locations entry; page revision updated to v3.3.3.SummaryDifference0.2%

- Check90 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.